144 related articles for article (PubMed ID: 11322122)
21. Value of brain magnetic resonance imaging and tumor markers in the diagnosis and treatment of intracranial germinoma in children.
Tao Y; Lian D; Hui-juan Z; Hui P; Zi-meng J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Apr; 33(2):111-5. PubMed ID: 21529434
[TBL] [Abstract][Full Text] [Related]
22. Analysis of long-term treatment of intracranial germinoma.
Shirato H; Nishio M; Sawamura Y; Myohjin M; Kitahara T; Nishioka T; Mizutani Y; Abe H; Miyasaka K
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):511-5. PubMed ID: 9112446
[TBL] [Abstract][Full Text] [Related]
23. Re-evaluation of the significance of cerebrospinal fluid human chorionic gonadotropin in detecting intracranial ectopic germinomas.
Tian C; Shi Q; Pu C; Huang X; Yu S; Zhang J; Huang D; Wang X; Liu R
J Clin Neurosci; 2011 Feb; 18(2):223-6. PubMed ID: 21163658
[TBL] [Abstract][Full Text] [Related]
24. Radiation therapy for primary intracranial germ-cell tumors.
Wolden SL; Wara WM; Larson DA; Prados MD; Edwards MS; Sneed PK
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):943-9. PubMed ID: 7607968
[TBL] [Abstract][Full Text] [Related]
25. The role of cerebrospinal fluid cytology in radiotherapy planning for intracranial germinoma.
Shibamoto Y; Oda Y; Yamashita J; Takahashi M; Kikuchi H; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1089-94. PubMed ID: 8083078
[TBL] [Abstract][Full Text] [Related]
26. A multimodal approach including craniospinal irradiation improves the treatment outcome of high-risk intracranial nongerminomatous germ cell tumors.
Kim JW; Kim WC; Cho JH; Kim DS; Shim KW; Lyu CJ; Won SC; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):625-31. PubMed ID: 22420971
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of alpha-fetoprotein, human chorionic gonadotropin and carcinoembryonic antigen in patients with primary intracranial germ cell tumors.
Arita N; Ushio Y; Hayakawa T; Uozumi T; Watanabe M; Mori T; Mogami H
Oncodev Biol Med; 1980; 1(4-5):235-40. PubMed ID: 6169060
[TBL] [Abstract][Full Text] [Related]
28. A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of the central nervous system.
Allen JC; DaRosso RC; Donahue B; Nirenberg A
Cancer; 1994 Aug; 74(3):940-4. PubMed ID: 8039122
[TBL] [Abstract][Full Text] [Related]
29. Serum and cerebrospinal fluid human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) in intracranial germ cell tumors.
Seregni E; Massimino M; Nerini Molteni S; Pallotti F; van der Hiel B; Cefalo G; Spreafico F; Fossati F; Bombardieri E
Int J Biol Markers; 2002; 17(2):112-8. PubMed ID: 12113577
[TBL] [Abstract][Full Text] [Related]
30. Preliminary observations for a new treatment in children with primary intracranial yolk sac tumor or embryonal carcinoma. Report of five cases.
Ushio Y; Kochi M; Kuratsu J; Itoyama Y; Marubayashi T
J Neurosurg; 1999 Jan; 90(1):133-7. PubMed ID: 10413166
[TBL] [Abstract][Full Text] [Related]
31. An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors.
Hu M; Guan H; Lau CC; Terashima K; Jin Z; Cui L; Wang Y; Li G; Yao Y; Guo Y; Li YM; Zhong D; Xiao J; Wan X; Lian X; Feng F; Ren H; Zhao Y; Cheng X; Gu F
Eur J Med Res; 2016 Mar; 21():10. PubMed ID: 26968839
[TBL] [Abstract][Full Text] [Related]
32. Two unusual recurrences of intracranial germinoma.
Strojan P; Popović M; Petric-Grabnar G; Zupancic N; Jereb B
Pediatr Hematol Oncol; 1996; 13(4):381-5. PubMed ID: 8837145
[TBL] [Abstract][Full Text] [Related]
33. Tumor markers at the time of recurrence in patients with germ cell tumors.
Trigo JM; Tabernero JM; Paz-Ares L; García-Llano JL; Mora J; Lianes P; Esteban E; Salazar R; López-López JJ; Cortés-Funes H
Cancer; 2000 Jan; 88(1):162-8. PubMed ID: 10618619
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy.
Ono N; Isobe I; Uki J; Kurihara H; Shimizu T; Kohno K
Neurosurgery; 1994 Oct; 35(4):615-20; discussion 620-1. PubMed ID: 7528902
[TBL] [Abstract][Full Text] [Related]
35. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
36. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89.
Calaminus G; Bamberg M; Harms D; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Neuropediatrics; 2005 Apr; 36(2):71-7. PubMed ID: 15822019
[TBL] [Abstract][Full Text] [Related]
37. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
[TBL] [Abstract][Full Text] [Related]
38. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
[TBL] [Abstract][Full Text] [Related]
39. Multifocal intracranial germinoma with raised tumour markers in serum but not in CSF and with carcinoma in situ of the testis.
Jorsal T; Rørth M
Acta Oncol; 2012 Jan; 51(1):127-9. PubMed ID: 21859353
[No Abstract] [Full Text] [Related]
40. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
